NCT00325507 2020-10-19
Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma
Oxford BioMedica
Phase 2 Completed
Oxford BioMedica
Oxford BioMedica
Oxford BioMedica
University of Oxford
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Wales Cancer Trials Unit
Cancer Research UK